Trial Profile
Clinical Experience with ertapenem in acute pyelonephritis due to ESBL producing enterobacteriaceae
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Pyelonephritis
- Focus Therapeutic Use
- Sponsors MSD Pharmaceuticals
- 21 Jun 2017 New trial record